Comparative ultrastructural studies of the alterations to mouse lung parenchyma during Trichinella spiralis or Toxocara canis infection

Parasite Immunology

Volumn 34, Issue 10, 2012, Pages 455-463

  Dabrowska, J ^a   Walski, M ^a,b   Dybicz, M ^a   Doligalska, M ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Charcot Leyden crystal; Electron microscopic evaluation; Lung parenchyma; Toxocara canis; Trichinella spiralis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; LUNG PARENCHYMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXOCARA CANIS; TOXOCARIASIS; TRICHINELLA SPIRALIS; TRICHINOSIS; ULTRASTRUCTURE;

ANIMALS; LUNG; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; TIME FACTORS; TOXOCARA CANIS; TOXOCARIASIS; TRICHINELLA SPIRALIS; TRICHINELLOSIS;

MUS; TOXOCARA CANIS; TRICHINELLA SPIRALIS;

EID: 84866155883     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2012.01381.x     Document Type: Article

References (30)

1. Despommier DD. How does Trichinella spiralis make itself home? Parasitol Today 1998; 14: 318-323.
2. Dzik JM, Golos B, Jagielska L, Kapala A & Walajtys-Rode E. Early response of guinea-pig lungs to Trichinella spiralis infection. Parasite Immunol 2002; 24: 369-379.
3. Venturiello SM, Verzoletti ML, Constantino SN, Forasitiero MA & Roux ME. Early pulmonary response in rats infected with Trichinella spiralis. Parasitology 2007; 134: 281-288.
4. Kociecka W. Trichinellosis: human disease, diagnosis and treatment. Vet Parasitol 2000; 93: 365-383.
5. Cottin V & Cordier J-F. Eosinophilic pneumonias. Allergy 2005; 60: 841-857.
6. Harley JP & Gallicchio V. Growth of Trichinella spiralis larvae from birth to day 13 postinoculation in the male albino rat. J Parasitol 1971; 57: 781-786.
7. Glickman LT & Summers BA. Epidemiology and pathogenesis of zoonotic toxocariasis. Epidemiol Rev 1983; 3: 230-250.
8. Glickman LT, Magnaval JF, Domanski LM, et al. Visceral larva migrans in French adults: a new disease syndrome? Am J Epidemiol 1987; 125: 1019-1034.
9. Sakai S, Shida Y, Takahashi N, et al. Pulmonary lesions associated with visceral larva migrans due to Ascaris suum or Toxocara canis imaging of six cases. Am J Roentgenol 2006; 186: 1697-1702.
10. Pinelli E, Brandes J, Dormans J, Fonville M, Hamilton CM & van der Giessen J. Toxocara canis: effect of inoculum size on pulmonary pathology and cytokine expression in BALB/c mice. Exp Parasitol 2007; 115: 76-82.
11. Gottstein B & Piarroux B. Current trends in tissue-affecting helminths. Parasite 2008; 15: 291-298.
12. Kolodziej-Sobocinska M, Dziemian E & Machnicka-Rowinska B. Inhibition of nitric oxide production by aminoguanidine influences the number of Trichinella spiralis parasites in infected "low responders" (C57BL/6) and "high responders" (BALB/c) mice. Parasitol Res 2006; 99: 194-196.
13. Wakelin P, Goyalt PK, Dehlawit MS & Hermaneks J. Immune responses to Trichinella spiralis and T. pseudospiralis in mice. Immunology 1994; 81: 475-479.
14. Meyer KC. Aging. Proc Am Thorac Soc 2005; 2: 433-439.
15. Walski M, Pokorski M, Antosiewicz J, et al. Pulmonary surfactant: ultrastructural features and putative mechanisms of aging. J Physiol Pharmacol 2009; 60: 121-125.
16. Gentilini MV, Nunez GG, Rouxb ME & Venturiello SM. Trichinella spiralis infection rapidly induces lung inflammatory response. The lung asthesite of helminthocytotoxic activity. Immunobiology 2011; 216: 1054-1063.
17. Dudek SM & Garcia JGN. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91: 1487-1500.
18. Groniowski J, Walski M, Cellary-Walska R & Groniowski M. Ultrastructural alterations of pulmonary surfactant in rat lungs after inhibition of protein synthesis by puromycin. Folia Histochem Cytobiol 1991; 29: 59-66.
19. Lewis JF & Veldhuizen R. The role exogenous surfactant in the treatment of acute lung insury. Ann Rev Physiol 2003; 65: 613-642.
20. Matthay MA, Folkesson HG & Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002; 82: 569-600.
21. Walski M, Grytner-Zie{ogonek}cina B & Frontczak-Baniewicz M. Morphological features of lung surfactant formation. Alterations in its structure after defect of some proteins and lung aging. Polish Geront 2005; 13: 81-187.
22. Mc Cormack FX, King TE, Voelker DR, Robinson PC & Manson RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir 1991; 144: 160-166.
23. Williams MC. Alveolar type I cells: molecular phenotype and development. Annu Rev Physiol 2003; 65: 669-692.
24. Pinelli E, Withagen C, Fonville M, et al. Persistent airway hyper-responsiveness and inflammation in Toxocara canis- infected BALB/c mice. Clin Exp Allergy 2005; 35: 826-832.
25. Brain JD. Mechanisms, measurement and significance of lung macrophage function. Environ Health Perspect 2005; 97: 5-10.
26. Dzik JM, Zielinski Z, Ciesla J & Walajtys-Rode E. Trichinella spiralis infection enhances protein kinase C phosphorylation in guinea pig alveolus macrophages. Parasite Immunol 2010; 32: 209-220.
27. El-Hashimi W. Charcot-Leyden crystals. Am J Pathol 1971; 65: 311-324.
28. Turner OC, Keefe RG, Sugawara I, Yamada H & Orme IM. SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis. Infect Immun 2003; 71: 5266-5272.
29. Zyngier FR & Brockbank A. Electron microscopy of the lung in experimental Toxocara canis infection. Ann Trop Med Parasitol 1974; 68: 229-233.
30. Huggins ML & Wakelin D. Lung eosinophilia in response to intravenously injected Trichinella spiralis. Appl Parasitol 1996; 37: 87-95.